Media Summary: At the 24th Congress of the European Hematology Association (EHA), Catherine Thieblemont from the Hôpital Saint-Louis, Paris, ... Adam Olszewski, MD, Brown University, Providence, RI, shares findings from a Phase II trial (NCT04792502) of mosunetuzumab ... Dr. Janet Pope discusses a subanalysis of the tofacitinib 1133
Augment Study Post Hoc Analysis In Mzl - Detailed Analysis & Overview
At the 24th Congress of the European Hematology Association (EHA), Catherine Thieblemont from the Hôpital Saint-Louis, Paris, ... Adam Olszewski, MD, Brown University, Providence, RI, shares findings from a Phase II trial (NCT04792502) of mosunetuzumab ... Dr. Janet Pope discusses a subanalysis of the tofacitinib 1133 Video abstract of methodology paper "A gender-medicine Jennifer Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, comments on the results of a Arun Azad, PhD, discusses the results of the
Andrea Apolo, MD, of the National Cancer Institute, Bethesda, MD, describes the John N. Allan, MD, reviews the diagnostic workup and treatment options used in the case of a 65-year-old male with ... Ariela Noy, MD, highlights first-line treatment options that are indicated for patients with advanced marginal zone lymphoma. John Leonard, MD, from Weill Cornell Medical College, New York City, NY, discusses the Phase III Kim Linton, MBChB, MRCP, PhD, FRCP, University of Manchester and The Christie NHS Foundation Trust, Manchester, UK, ...
